OpenBilldrug price receipt

NADAC week of 2026-10-14

BUPROPION HCL XL 150 MG TABLET

For 30 tablets

Pharmacies pay

$2.35 filed

30 × $0.07846 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$12.11 filed

30 × $0.40383 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

5.1× estimated

Medicare paid 5.1× what pharmacies pay.

Part D averages every strength and form sold under “Bupropion XL” / “Bupropion HCl” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$7.70 estimated

$2.35 + $0.35 (15%) + $5.00 fee per fill = $7.70

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

BUPROPION HCL XL 150 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “bupropion hydrochloride”, “bupropion hydrochloride (xl)” and “bupropion”, as its NDCs’ listings variously write the nonproprietary name, under the trade name “Bupropion Hydrochloride XL”.

FDA gives its dosage form as “tablet, film coated, extended release”, “tablet, extended release” and “tablet” and its route as oral.

FDA lists 20 labelers (the companies named on the label) for its NDCs, among them Actavis Pharma, Inc., Major Pharmaceuticals and Rising Pharma Holdings, Inc.

FDA’s Established Pharmacologic Class for it is Aminoketone.

The NADAC file of 2026-10-14 prices it under 51 NDCs (National Drug Codes); the FDA directory lists 47 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $2.35 for 30 tablets (30 × $0.07846 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 20 labelers

LabelerNDCsPharmacies pay per unit
BluePoint Laboratories5$0.07846 per EA filed
Mullan Pharmaceutical Inc.4$0.07846 per EA filed
Rising Pharma Holdings, Inc.4$0.07846 per EA filed
Accord Healthcare Inc.3$0.07846 per EA filed
Actavis Pharma, Inc.3$0.07846 per EA filed
Epic Pharma, LLC3$0.07846 per EA filed
Granules Pharmaceuticals Inc.3$0.07846 per EA filed
Lupin Pharmaceuticals, Inc.3$0.07846 per EA filed
ScieGen Pharmaceuticals,Inc.3$0.07846 per EA filed
Zydus Pharmaceuticals USA Inc.3$0.07846 per EA filed
Cipla USA., Inc.2$0.07846 per EA filed
Major Pharmaceuticals2$0.07846 per EA filed
Vitruvias Therapeutics2$0.07846 per EA filed
American Health Packaging1$0.07846 per EA filed
AvPAK1$0.07846 per EA filed
Camber Pharmaceuticals, Inc.1$0.07846 per EA filed
Chartwell RX, LLC1$0.07846 per EA filed
Dr Reddys Laboratories Inc1$0.07846 per EA filed
Oryza pharmaceuticals Inc.1$0.07846 per EA filed
Quallent Pharmaceuticals Health LLC1$0.07846 per EA filed
Not listed as a package in the FDA directory4$0.07846 per EA filed
All 51 NDCs, with labeler and price
  • 00591-3331-05 · Actavis Pharma, Inc. · $0.07846 per EA · eff. 2026-09-23 filed
  • 00591-3331-19 · Actavis Pharma, Inc. · $0.07846 per EA · eff. 2026-09-23 filed
  • 00591-3331-30 · Actavis Pharma, Inc. · $0.07846 per EA · eff. 2026-09-23 filed
  • 00904-7505-04 · Major Pharmaceuticals · $0.07846 per EA · eff. 2026-09-23 filed
  • 00904-7505-61 · Major Pharmaceuticals · $0.07846 per EA · eff. 2026-09-23 filed
  • 16571-0862-03 · Rising Pharma Holdings, Inc. · $0.07846 per EA · eff. 2026-09-23 filed
  • 16571-0862-09 · Rising Pharma Holdings, Inc. · $0.07846 per EA · eff. 2026-09-23 filed
  • 16571-0862-12 · Rising Pharma Holdings, Inc. · $0.07846 per EA · eff. 2026-09-23 filed
  • 16571-0862-50 · Rising Pharma Holdings, Inc. · $0.07846 per EA · eff. 2026-09-23 filed
  • 16729-0443-10 · Accord Healthcare Inc. · $0.07846 per EA · eff. 2026-09-23 filed
  • 16729-0443-15 · Accord Healthcare Inc. · $0.07846 per EA · eff. 2026-09-23 filed
  • 16729-0443-16 · Accord Healthcare Inc. · $0.07846 per EA · eff. 2026-09-23 filed
  • 31722-0487-05 · Camber Pharmaceuticals, Inc. · $0.07846 per EA · eff. 2026-09-23 filed
  • 42806-0414-05 · Epic Pharma, LLC · $0.07846 per EA · eff. 2026-09-23 filed
  • 42806-0414-09 · Epic Pharma, LLC · $0.07846 per EA · eff. 2026-09-23 filed
  • 42806-0414-30 · Epic Pharma, LLC · $0.07846 per EA · eff. 2026-09-23 filed
  • 43598-0655-30 · Dr Reddys Laboratories Inc · $0.07846 per EA · eff. 2026-09-23 filed
  • 50228-0144-05 · ScieGen Pharmaceuticals,Inc. · $0.07846 per EA · eff. 2026-09-23 filed
  • 50228-0144-30 · ScieGen Pharmaceuticals,Inc. · $0.07846 per EA · eff. 2026-09-23 filed
  • 50228-0144-90 · ScieGen Pharmaceuticals,Inc. · $0.07846 per EA · eff. 2026-09-23 filed
  • 50268-0133-11 · not listed as a package in the FDA directory · $0.07846 per EA · eff. 2026-09-23 filed
  • 50268-0133-13 · AvPAK · $0.07846 per EA · eff. 2026-09-23 filed
  • 60687-0782-01 · American Health Packaging · $0.07846 per EA · eff. 2026-09-23 filed
  • 60687-0782-11 · not listed as a package in the FDA directory · $0.07846 per EA · eff. 2026-09-23 filed
  • 62135-0875-30 · Chartwell RX, LLC · $0.07846 per EA · eff. 2026-09-23 filed
  • 68001-0519-04 · BluePoint Laboratories · $0.07846 per EA · eff. 2026-09-23 filed
  • 68001-0519-05 · BluePoint Laboratories · $0.07846 per EA · eff. 2026-09-23 filed
  • 68001-0613-03 · BluePoint Laboratories · $0.07846 per EA · eff. 2026-09-23 filed
  • 68001-0613-04 · BluePoint Laboratories · $0.07846 per EA · eff. 2026-09-23 filed
  • 68001-0613-05 · BluePoint Laboratories · $0.07846 per EA · eff. 2026-09-23 filed
  • 68180-0319-02 · Lupin Pharmaceuticals, Inc. · $0.07846 per EA · eff. 2026-09-23 filed
  • 68180-0319-06 · Lupin Pharmaceuticals, Inc. · $0.07846 per EA · eff. 2026-09-23 filed
  • 68180-0319-09 · Lupin Pharmaceuticals, Inc. · $0.07846 per EA · eff. 2026-09-23 filed
  • 68382-0353-05 · Zydus Pharmaceuticals USA Inc. · $0.07846 per EA · eff. 2026-09-23 filed
  • 68382-0353-06 · Zydus Pharmaceuticals USA Inc. · $0.07846 per EA · eff. 2026-09-23 filed
  • 68382-0353-16 · Zydus Pharmaceuticals USA Inc. · $0.07846 per EA · eff. 2026-09-23 filed
  • 69097-0071-12 · Cipla USA., Inc. · $0.07846 per EA · eff. 2026-09-23 filed
  • 69097-0875-05 · CIPLA USA INC., · $0.07846 per EA · eff. 2026-09-23 filed
  • 69367-0288-05 · not listed as a package in the FDA directory · $0.07846 per EA · eff. 2026-09-23 filed
  • 69367-0288-09 · not listed as a package in the FDA directory · $0.07846 per EA · eff. 2026-09-23 filed
  • 69680-0157-90 · Vitruvias Therapeutics · $0.07846 per EA · eff. 2026-09-23 filed
  • 69680-0157-92 · Vitruvias Therapeutics · $0.07846 per EA · eff. 2026-09-23 filed
  • 70010-0784-03 · Granules Pharmaceuticals Inc. · $0.07846 per EA · eff. 2026-09-23 filed
  • 70010-0784-05 · Granules Pharmaceuticals Inc. · $0.07846 per EA · eff. 2026-09-23 filed
  • 70010-0784-09 · Granules Pharmaceuticals Inc. · $0.07846 per EA · eff. 2026-09-23 filed
  • 72516-0035-50 · Oryza pharmaceuticals Inc. · $0.07846 per EA · eff. 2026-09-23 filed
  • 82009-0051-05 · Quallent Pharmaceuticals Health LLC · $0.07846 per EA · eff. 2026-09-23 filed
  • 83301-0024-01 · Mullan Pharmaceutical Inc. · $0.07846 per EA · eff. 2026-09-23 filed
  • 83301-0024-02 · Mullan Pharmaceutical Inc. · $0.07846 per EA · eff. 2026-09-23 filed
  • 83301-0024-03 · Mullan Pharmaceutical Inc. · $0.07846 per EA · eff. 2026-09-23 filed
  • 83301-0024-04 · Mullan Pharmaceutical Inc. · $0.07846 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

10 other products in the NADAC file share an FDA nonproprietary name with BUPROPION HCL XL 150 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
BUPROPION HCL 75 MG TABLET
generic · tablet, film coated / tablet
$0.09282 per EA filed
eff. 2026-09-23
$0.28918 per EA filed
Part D 2024 average
BUPROPION HCL 100 MG TABLET
generic · tablet, film coated / tablet
$0.11295 per EA filed
eff. 2026-09-23
$0.28918 per EA filed
Part D 2024 average
BUPROPION HCL SR 100 MG TABLET
generic · tablet, film coated, extended release / tablet, extended release
$0.0679 per EA filed
eff. 2026-09-23 to 2026-09-30
$0.23239 per EA filed
Part D 2024 average
BUPROPION HCL SR 150 MG TABLET
generic · tablet, film coated, extended release / tablet, extended release
$0.07985 to $0.25221 per EA filed
eff. 2026-09-23
$0.23239 per EA filed
Part D 2024 average
BUPROPION HCL SR 200 MG TABLET
generic · tablet, film coated, extended release / tablet, extended release
$0.10362 per EA filed
eff. 2026-09-23
$0.23239 per EA filed
Part D 2024 average
BUPROPION HCL XL 150 MG TABLET this page
generic · tablet, film coated, extended release / tablet, extended release / tablet
$0.07846 per EA filed
eff. 2026-09-23
$0.40383 per EA filed
Part D 2024 average
BUPROPION HCL XL 300 MG TABLET
generic · tablet, extended release / tablet, film coated, extended release / tablet
$0.10041 per EA filed
eff. 2026-09-23
$0.40383 per EA filed
Part D 2024 average
BUPROPION HCL XL 450 MG TABLET
generic · tablet, film coated, extended release / tablet, extended release
$7.99556 per EA filed
eff. 2026-09-23
$0.40383 per EA filed
Part D 2024 average
WELLBUTRIN SR 100 MG TABLET
brand · tablet, film coated
$7.06228 per EA filed
eff. 2026-09-23
$8.87963 per EA filed
Part D 2024 average
WELLBUTRIN SR 150 MG TABLET
brand · tablet, film coated
$7.51608 per EA filed
eff. 2026-09-23
$8.87963 per EA filed
Part D 2024 average
WELLBUTRIN SR 200 MG TABLET
brand · tablet, film coated
$13.97633 per EA filed
eff. 2026-09-23
$8.87963 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 51 NDCs’ NADAC prices is $0.07846 per EA filed.

Of the 11 other products in FDA’s Aminoketone class priced per EA, 10 have a higher middle NADAC price and 1 a lower one. The one in the middle is BUPROPION HCL 100 MG TABLET, at $0.11295 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $12.11 for 30 tablets, at an average of $0.40383 per EA in 2024 (2024-01-01 to 2024-12-31) for “Bupropion XL” and “Bupropion HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 6,831,216 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for BUPROPION HCL XL 150 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Bupropion XL / Bupropion HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.